518
Views
13
CrossRef citations to date
0
Altmetric
Research Article

New N4-substituted piperazine naphthamide derivatives as BACE-1 inhibitors

, , , , , & show all
Pages 181-187 | Received 20 Aug 2007, Accepted 08 Oct 2007, Published online: 01 Feb 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Olga V. Nevzglyadova, Ekaterina V. Mikhailova, Triana R. Amen, Valeriy V. Zenin, Alexey V. Artemov, Elena I. Kostyleva, Daria A. Mezhenskaya, Dmitry I. Rodin, Alsu F. Saifitdinova, Mikhail A. Khodorkovskii, Svetlana V. Sarantseva & Tonu R. Soidla. (2015) Yeast red pigment modifies Amyloid beta growth in Alzheimer disease models in both Saccharomyces cerevisiae and Drosophila melanogaster. Amyloid 22:2, pages 100-111.
Read now

Articles from other publishers (12)

Mariana G. Fronza, Diego Alves, Domenico Praticò & Lucielli Savegnago. (2023) The neurobiology and therapeutic potential of multi-targeting β-secretase, glycogen synthase kinase 3β and acetylcholinesterase in Alzheimer’s disease. Ageing Research Reviews 90, pages 102033.
Crossref
Olga V. Nevzglyadova, Ekaterina V. Mikhailova & Tonu R. Soidla. (2022) Yeast red pigment, protein aggregates, and amyloidoses: a review. Cell and Tissue Research 388:2, pages 211-223.
Crossref
Eva Mezeiova, Katarina Chalupova, Eugenie Nepovimova, Lukas Gorecki, Lukas Prchal, David Malinak, Kamil Kuca, Ondrej Soukup & Jan Korabecny. (2019) Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease. Current Alzheimer Research 16:9, pages 772-800.
Crossref
Ümide Demir Özkay, Özgür Devrim Can, Begüm Nurpelin Sağlık & Nazlı Turan. (2017) A benzothiazole/piperazine derivative with acetylcholinesterase inhibitory activity: Improvement in streptozotocin-induced cognitive deficits in rats. Pharmacological Reports 69:6, pages 1349-1356.
Crossref
Rahul Shukla, Aamer Saeed, Jim Simpson & Deepak Chopra. (2017) Quantitative investigation of C–H⋯π and other intermolecular interactions in a series of crystalline N-(substituted phenyl)-2-naphthamide derivatives. CrystEngComm 19:36, pages 5473-5491.
Crossref
Dawid Panek, Anna Więckowska, Tomasz Wichur, Marek Bajda, Justyna Godyń, Jakub Jończyk, Kamil Mika, Jana Janockova, Ondrej Soukup, Damijan Knez, Jan Korabecny, Stanislav Gobec & Barbara Malawska. (2017) Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation. European Journal of Medicinal Chemistry 125, pages 676-695.
Crossref
Poonam Meena, Apra Manral, Vikas Saini & Manisha Tiwari. (2014) Protective Effects of a Piperazine Derivative [N-{4-[4-(2-methoxy-phenyl)-piperazin-1-yl]-phenyl} Carbamic Acid Ethyl Ester] Against Aluminium-Induced Neurotoxicity: Insights From In Silico and In Vivo Studies. Neurotoxicity Research 27:3, pages 314-327.
Crossref
D. I. Rodin, A. L. Schvarzman & S. V. Saranzeva. (2014) Modern approach in the therapy of Alzheimer's disease. The Scientific Notes of the I. P. Pavlov St. Petersburg State Medical University 21:1, pages 6-10.
Crossref
Fabienne Leidel, Martin Eiden, Markus Geissen, Thomas Hirschberger, Paul Tavan, Armin Giese, Hans A. Kretzschmar, Hermann Schätzl & Martin H. Groschup. (2014) Piperazine derivatives inhibit PrP/PrPres propagation in vitro and in vivo. Biochemical and Biophysical Research Communications 445:1, pages 23-29.
Crossref
Jihong KangSerge Rivest. (2012) Lipid Metabolism and Neuroinflammation in Alzheimer's Disease: A Role for Liver X Receptors. Endocrine Reviews 33:5, pages 715-746.
Crossref
Ümide Demir Özkay, Özgür Devrim Can, Yusuf Özkay & Yusuf Öztürk. (2012) Effect of benzothiazole/piperazine derivatives on intracerebroventricular streptozotocin-induced cognitive deficits. Pharmacological Reports 64:4, pages 834-847.
Crossref
Daniela Galimberti & Elio Scarpini. (2011) Disease-modifying treatments for Alzheimer’s disease. Therapeutic Advances in Neurological Disorders 4:4, pages 203-216.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.